Tumor cells over expressing the RTK EGFR are associated with poor prognosis due to phosphorylation-induced activation of AKT, STAT, and ERK pathways and to tumor cell proliferation, resistance to apoptosis, and metastasis (Esposito et al., 2011; Li et al., 2011). This evidence concerns the gene EGFR and neoplasm.